Mount Sinai School of Medicine And EXACT Sciences Corporation Announce Publication Of Multi-Center Study Results On Stool DNA Testing For Colon Cancer

NEW YORK & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Mount Sinai School of Medicine and EXACT Sciences Corporation (NASDAQ: EXAS) announced today the publication of results from a prospective, multi-center study of stool DNA testing. The study found that the test demonstrated an 88% sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer’s location in the colon. The study was published online in the American Gastroenterological Association’s journal, Clinical Gastroenterology and Hepatology, and will appear in the January 2007 print issue.